## Abstract The reproductive effect of __N,N__βdimethylformamide (DMF) administered epicutaneously to rats was examined. The rats were dosed on gestation days 6β15 or on gestation days 1β20 at dose levels of up to 2 ml DMF kg^β1^ body weight. Body weight, weight gain and pregnancy rate were reduced
Benzofuranyl ureas with potent cardiovascular teratogenicity in rats
β Scribed by Solomon, H.M.; Wier, P.J.; Johnson, C.M.; Posobiec, L.M.; Rendemonti, J.E.; Rumberger, D.F.
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 214 KB
- Volume
- 61
- Category
- Article
- ISSN
- 0040-3709
No coin nor oath required. For personal study only.
β¦ Synopsis
Studies of embryo-fetal development in rats were conducted with two 5-lipoxygenase inhibitors. SB-202235 (1,000 mg/kg/day) or SB-210661 (50, 100, or 500 mg/kg/day) was administered orally by gavage to female rats on days 6-17 postcoitus (pc) or days 7-16 pc. SB-202235 (1,000 mg/kg/day) and SB-210661 (100 mg/kg/day) reduced maternal body weight gain for the treatment period by 16% and 21%, respectively, relative to controls. SB-202235 (1,000 mg/kg/day) or SB-210661 (50 or 100 mg/kg/day), did not affect numbers of resorptions, dead or live fetuses/litter, but 500 mg/kg/day of SB-210661 caused 100% embryo lethality. SB-202235 (1,000 mg/kg/day) and SB-210661 (50 and 100 mg/kg/day) reduced fetal body weight by 15-30% and produced extensive cardiovascular malformations, as well as diaphragmatic hernias. SB-210661 also caused thymic abnormalities and cryptorchidism.
π SIMILAR VOLUMES
A conjugate of doxorubicin and glutathione via glutaraldehyde (GSH-DXR) inhibited glutathione S-transferase (GST) activity of rat hepatoma AH66 cells, and treatment of the cells with GSH-DXR induced caspase-3 activation and DNA fragmentation. After treatment of AH66 cells with 0.1 M GSH-DXR, GST-P (
The Chernoff and Kavlock in vivo assay was used to study the teratogenic potential of ethylene glycol monomethyl ether (EGME). It was administered to pregnant rats on days 6-17 (inclusive) of gestation by the dermal route at an application rate of 10 ml kg-' body weight of 3%, lo%, 30% and 100% EGME